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Sununary 
Antibodies  bearing  the  T15  idiotype dominate  the  murine primary  immune response  to 
phosphocholine (PC). Analysis of antigen binding of antibodies derived from VI:DFL16.1:J.1 
(V.1) germline and N region-derived variant heavy (H) chains and g22, K24, and K8 light (L) 
chains demonstrates that the T15H:K22L (T15) antibody binds PC at least 20-40 times better 
than other antibodies derived from alternate germline forms of the V.1 H chain and g22, K24, 
or K8 L chains.  To achieve af~nities  in the same range as the T15  antibody, K24 and Ic8 L 
chain-containing antibodies must have H  chains derived from variant N  region or somatically 
mutated V.1 genes. Single amino acid differences at the VD junction of the various germline 
and N region variant V.1 H  chains dictate the L chain that can associate with the H  chain to 
produce a PC-specific antibody. Several H:L combinations give rise to T15 or M167 idiotype- 
positive antibodies that lack specificity for PC, and single amino acid substitutions or insertions 
at the V.I:D junction result in the loss of T15 or M167 idiotopes. Based on these observations, 
our data support a molecular model involving both preferential gene rearrangement and antigen- 
driven B cell selection  to explain T15 idiotype dominance in the immune response to PC. In 
the absence of N region diversification, large numbers of neonatal B cells bearing the T15H:K22L 
surface immunoglobulin M (slgM) receptors would be selected and expanded by autologous or 
environmental PC antigen into the long-lived peripheral B cell pool. 
T 
he primary antibody response to PC in normal inbred 
mice is dominated by antibodies expressing H and L chain 
products of the V.1 and V~22 germline genes (1, 2). These 
antibodies are identical to the antibody produced by the T15 
plasmacytoma (3). The T15 clone of B cells is present in the 
mouse spleen at a higher frequency than any other individual 
clone of B cells and comprises >75% of all phosphocholine 
(PC)l-specific  B cells in normal mice (4).  The reasons for 
T15-Id dominance of the anti-PC immune response are not 
fully  understood;  however,  idiotype  network  selection, 
binding-site affinity, and preferential V gene expression have 
I Abbreviation used in this paper: PC,  phosphocholine. 
all been suggested. A. J. Feeney (5) has recently shown that 
over 50% of the V1:DFL16.1junctions produced in neonatal 
pre-B cells have prototypic T15 V-D junctional sequences, 
and has hypothesized that this preferential recombination of 
these germline genes would account for the dominance of 
T15 clones in the anti-PC repertoire.  If the prototypic T15H 
chain is preferentially  produced and this H  chain can only 
form a PC-specific antibody with a K22 L chain, the subse- 
quent receptor-driven selection and amplification of this clone 
into a long-lived B cell pool could account for T15-Id domi- 
nance. This hypothesis is supported by our recent observa- 
tion (6, 7) that PC-specific B cells in M167 H  chain trans- 
genic mice are selected and amplified by a receptor-mediated, 
antigen-driven process  after  they emerge from  the  bone 
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planation for T15-Id dominance if: (a) the T15 prototype H 
chain binds PC with a K, of 10  s or higher when associated 
with L chains other than K22; or (b) antibodies containing 
alternate germline-derived V.1 sequences can bind PC with 
an affinity in the same range as T15.  From the data in this 
paper,  it appears that  these latter two conditions probably 
cannot  occur in vivo. 
X-ray crystallographic (8-10), amino acid sequencing (11, 
12), and idiotypic (3) analysis of anti-PC binding antibodies 
(13, 14) have provided a detailed understanding of the corre- 
lations between antibody structure and antigen binding (for 
review see reference 15). Virtually all PC-binding mouse an- 
tibodies employ three L chains as represented by the BALB/c 
myeloma  proteins  T15  (V~22),  M603  (V~8),  and  M167 
(V~24)  (8-20).  These three L chains are only 45-74,%  ho- 
mologous to one another in amino acid sequences; however, 
they all use J~5 and exhibit the Tyr-Pro-Leu amino acid se- 
quence at position 94, 95, and 96 which provides the major 
L chain contact residues for PC (10,  15).  The H  chains 9 f 
the prototype T15, M603, and M167 PC-binding antibodies, 
which provide the majority of PC contact residues, are de- 
rived from a single germline V. gene (V.1) (21).  This V.1 
gene segment is rearranged  to DFL16.1 and J.1 during so- 
matic gene rearrangement,  and the major differences between 
these prototype H chains exist at VD and DJ junctions (t5, 
17-20, 22, 23). Claflin (18, 22) and Feeney (19, 20, 23) and 
their collaborators have demonstrated that pivotal, "family- 
specific" amino acid changes occur at the Vl:DFL16:ljunc- 
tion  of M603-  and M167-1ike  H  chains which distinguish 
these antibodies from the germline T15 sequence. These VD- 
junctional residues appear to dictate the L chain which can 
associate with these variant H chains to form PC-specific an- 
tibodies. Thus, in virtually all M603-1ike antibodies,  an in- 
variant Ash is found at position 95H in place of the germline- 
encoded Asp, and in the majority of M167-1ike  antibodies, 
an Ala has been inserted between Asp 95H and Tyr 96H of 
the T15 germline sequence (see Fig. 1). Although the GCA 
codon for Ala exists in the V1 germline gene, the insertion 
of an Ala or other amino acid at the VD junction of M167- 
like antibodies is generally accompanied by additional changes 
at  VD  or  DJ  junctions.  This  suggests  that  N  region 
diversification is required to generate this PC-binding H chain 
sequence. The Asp to Asn change (a G:A transversion) which 
occurs in the M603-1ike antibodies  also requires  N  region 
diversification of codon 95H in the V1 germline  sequence 
(George, J.,  S.  Penner,  J.  Weber, and J. L.  Claflin,  manu- 
script submitted for publication).  Thus,  the T15 prototype 
sequence may be the only H  chain  sequence derived from 
the joining  of V.1:DFL16.1:J.1  gene segments in  the ab- 
sence of N region diversification or somatic mutation which 
binds PC with an affinity sufficient for clonal expansion by 
autolog0us  or environmental  PC antigens. 
To address the molecular basis of T15-Id clonal dominance, 
we electroporated four different forms of the Vl:DFL16.1: 
J.1  genes  in  association  with  the  V,22,  V,8,  or  V~24 
PC-binding L chain genes into the SP2\0 myeloma cell line. 
By analyzing  the antibodies produced by these H-L chain 
pairs,  we determined which germline and somatic variants 
of the V,1 H  chain gene product generated PC-binding an- 
tibodies  when  combined  with  these  three  L  chains,  and 
whether this PC binding was dictated by the family-specific, 
VD-associated,  single-base changes discussed above. The results 
of these studies suggest that  the T15H:x22L antibody has 
the highest affinity for PC of the potential PC-binding V.1 
germline antibodies  analyzed, and thus, even without preferen- 
tial rearrangement  of the T15H sequence, this H:L combi- 
nation would be preferentially selected and expanded into the 
long-lived B cell pool. 
Materials and Methods 
Antibodies and ELISA.  The rat  anti-V.1  hybridoma  T68.3, 
which recognizes all antibodies carrying  a V,1 H chain and the 
anti-T15-Id hybridoma  T139.2 (24) were obtained  from Dr.  M. 
Scharff (Albert Einstein College of Medicine, Bronx,  NY). The 
binding-site-specific rat anti-M167-Id  hybridoma 28-5-15 (7), a 
nonbinding-site-specific  anti-M167-Id  (28-4-3),  and  the  anti- 
IgM~-allotype hybridoma (DS-1) (25) were obtained from Dr. D. 
Sieckmann (Naval Medical Research Institute, Bethesda, MD). The 
AB1.2 anti-T15-Id (26) and rat anti-mouse-to (HB-58) hybridomas 
were obtained from the American Type Culture Collection (Rock- 
ville, MD). The polyvalent rabbit anti-T15-Id and goat anti-mouse 
IgM (# specific) antibodies were produced as previously described 
(27, 28). ELISA for direct binding  to PC-BSA-coated microtiter 
plates and anti-/~ capture assays for detection of idiotypic and allo- 
typic markers have been described (29). The antibody level in tissue 
culture  supernatants  was adjusted to 1 #g/ml based on the #/ic 
capture assay. Anti-Id,  anti-aUotype, and direct PC-binding assays 
were then  carried out on a five-place 1:5 dilution  series of each 
supernatant,  Standard curves for each assay were generated using 
affinity-purified T15-Id + or M167-Id § IgM~-allotype antibodies 
from the HPCM2 or HPCM27 hybridomas (17), respectively. All 
assays were sensitive to a level of at least 10 ng/ml. 
H and L Chain Genes.  The M167-H and L chain (V~24) genes 
(30) were obtained  from Dr.  U.  Storb  (University  of Chicago, 
Chicago, IL). Dr. P. Tucker (University of Texas, Dallas, TX) sup- 
plied the S107 (T15) H and L chain (V,22) genes (31). The M603- 
like (T15-Asn) and M167-1ike (T15-Ala) V.1 genes were produced 
by PCK site-directed mutagenesis of a V.T15:# plasmid as de- 
scribed by Ho et al. (32). In brief, the V.T15 gene was altered by 
changing the GAT at 95H to an AAT to produce the T15-Asn gene 
and by inserting a GCA codon after the GAT at 95H to produce 
the T15-Ala gene. The critical VDJjunctions of the H chain genes 
and the translated amino acid sequences of these genes are shown 
in Fig. 1. The V,8 L chain gene was cloned from the PC-specific 
hybridoma 206.8D3 (22) into ~ EMBL4 arms as a 16.3-kb EcoKI 
genomic fragment.  This gene contains 3 kb of sequence 5' of the 
promoter and about 9.5 kb of sequence 3' of C, (Weber, J., and 
J. L. Claflin, manuscript  in preparation). 
Electroporation of  H and L Chain Genes.  Electroporation of lin- 
earized plasmids carrying H and L chain genes and the subsequent 
selection of geneticin (G418)-resistant cell lines has been described 
(7). Most electroporations  were done using the SP2\0 myeloma 
(33), an H and L chain-defident line, as the recipient cell line. How- 
ever, cell lines 9 and 12 (see Table 1) were derived by electropora- 
tion of the designated H chain gene into a V~8 L chain-only hy- 
bridoma  (301.2D7.7)  (34), and  cell line  11  was  produced  by 
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M603-1ike 
M167-1ike 
M167 
Nucleotide Sequence of VDJ-genes 
V~-I  VD-Junetion  DFLI6.1  DJ-Junction  3HI 
91  92  93  94  95  96  97  98  99  i00  lOOalO0bl00cl00d i01 102 
Tyr  Cys  Ala  Arg Asp  Ala 
TAC  TGT  GCA  AGA  CAT  GCA  CACAGTG  Tyr  Tyr  Gly  Set  Set  Tyr 
AAT  TACTGTG  TT  TAT TAC  TAC  GGT  ACT  AGC  TAC  CACAGTG Tyr  Trp  Tyr  Phe  Asp  Val 
Asn  CACAGTG TAC  TGG  TAr  TTC  CAT  GTC 
H-Chain Amino Acid Sequences 
91  92  93  94  95  96  97  98  99  I00  lOOalOObl00el00d i01 102 
Tyr  Cys  Ala  Ar  E  Asp  Tyr  Tyr  Gly  Ser  Ser  Tyr  Trp  Tyr  Phe  Asp  Val 
Tyr  Cys  Ala  Arg  Ash  Tyr  Tyr  Gly  Ser  Set  Tyr  Trp  Tyr  Phe  Asp  Val 
Tyr  Cys  Ala  Arg  Asp  AIa  Tyr  Tyr  Gly  Set  Set  Tyr  Trp  Tyr  Phe  Asp  Val 
Tyr  Cys  Ala  Arg Asp  Ala Asp  Tyr  Gly  Asn  Set  Tyr  Phe  Gly  Tyr  Phe  Asp  Val 
Figure  1.  The  nucleic  acid  se- 
quence  at  the  top represents  the 
germline sequence for the 3' end of 
V.1  gene,  the DFL16.1  diversity 
gene segment,  and the .I.1 joining 
segment. The translated amino acid 
sequence is shown above the DNA 
sequence with the T15H chain se- 
quence in bold. Alternate splicing, 
N region diversification, or somatic 
mutation of the T15 germline se- 
quence gives rise to the M603-1ike, 
M167-1ike,  or  M167  protein  se- 
quences shown in the bottom part 
of this figure. The amino acid num- 
bering  was  taken  from  Rudikoff 
(15). 
electroporation of the V~24 L chain gene into a J558L:M167# cell 
line obtained from Dr.  Carol Sibley (University of Washington, 
Seattle, WA). This cell line produces an IgM)~, V.l-Id + antibody 
that  does not bind PC. 
Results 
Analysis of TI5H Germline Antibodies.  The T15H  chain 
gene (Fig. 1) was electroporated into separate aliquots of SP2\0 
Table  1.  Characterization of Cell Lines Electroporated with PC-h'nding H and L  Chain Genes* 
T15-Id  M167-Id 
Cell  Transfected 
line  V  genes  K  IgM  ~  V,l-Id  T139.2  AB1.2  PolyV  28-5-15  28-4-3  PC-BSA 
1  VT15/~  +  +  +  + 
V,22 
2  VT15/z  +  +  +  - 
V,24 
3  VT15/~  +  +  +  - 
V,8 
4  VT15/z-Ala  +  +  +  + 
V,22 
5  VT15/z-Ala  +  +  +  - 
V,24 
6  VT15#-Ala  +  +  +  - 
V~8 
7  VT15#-Asn  +  +  +  + 
V,22 
8  VT15/z-Asn  +  +  +  - 
V,24 
9  VT15/~-Asn  +  +  +  - 
V~8 
10'  V167#  +  +  +  + 
V,22 
11'  V167#  +  +  +  - 
VK24 
12  V167/~  +  +  +  - 
V~8 
+  +  --  _  + 
--  +  +  -- 
+ 
--  + 
--  +  +  + 
+  +  -- 
+ 
+ 
--  + 
-  +  +  + 
* Cell lines designated  with ( + ) in a given assay produced  an antibody  that bound within a twofold range of the antibody  used to generate  the 
standard  curve;  (_+) a quantity 20-40-fold lower than  the standard  curve antibody was  obtained  at  the 1-#g/ml dilution; and  (-)  nothing was 
detected  at any dilution tested. 
* The data  for cell lines  10 and  11  have been  previously  published  in reference 7. 
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from PC-binding antibodies (Table 1, cell lines 1-3). As ex- 
pected, the antibodies produced by all combinations of elec- 
troporated H and L chain genes expressed K, #~-allotype, and 
VHI-Id markers.  The  homologous  T15  cell  line,  which 
resulted  from coelectroporation  of the T15H  and V~22L 
genes, produced a PC-BSA binding antibody that was indis- 
tinguishable from the IgMK HPCM2 (T15) hybridoma stan- 
dard in both binding affinity and idiotype expression (Table 
1, cell line 1). When the T15H chain gene was combined 
with  the  V~24L chain  gene  (Table  1,  cell  line  2),  the 
resulting  antibody expressed both the binding-site-specific 
(28-5-15) and nonsite-specific (28-4-3) M167 idiotopes, but 
it failed to bind PC-BSA. Combining the prototype T15H 
chain gene with the V~8L gene (Table 1, cell line 3), resulted 
in an antibody that exhibits none of the H:b-dependent T15 
or M167 idiotopes but that binds PC-BSA at a level 20-40- 
fold lower than the HPCM2 standard. The above  results dem- 
onstrate that the prototype T15H chain can form an anti-PC 
antibody with at least one of the other PC-binding L chains, 
but the T15H:K22L combination has a much higher affinity. 
Analysis of Germline T15-AIa H Chain Antibodies.  To ad- 
dress the question of whether or not other germline-derived 
V,l:DFL16.3:J.1  H chains besides the T15H can participate 
in the formation of PC-specific antibodies, the T15 gene was 
altered by PCR so that a GCA codon for alanine was in- 
serted at the VD junction. The insertion of an extra amino 
acid at this position, generally Ala, occurs in almost all anti- 
PC antibodies belonging to the M167/M511 family (19, 20). 
This T15-Ala H chain gene was then electroporated into sep- 
arate aliquots of SP2\0 cells along with one of the PC-binding 
L chain genes. The antibodies  from the resulting G418-resistant 
cell lines (Table 1, cell lines 4-6) were analyzed for binding 
to PC-BSA and idiotype expression. The antibodies composed 
of the variant T15-Ala H  chain and either V~22L (cell line 
4) or V~SL (cell line 6) fail to bind PC-BSA. It is interesting 
that the T15-Ala-H:K22L antibody expresses the T15 idio- 
topes detected by our polyvalent rabbit antibody and the rat 
T139.2 hybridoma, but the insertion of Ala between Asp 
95H and Tyr 96H destroys the T15 idiotope detected by the 
AB1.2 anti-T15 antibody (Table 1, cell line 4). The insertion 
of Ala at the VD junction of T15H not only destroys PC 
binding with the K22 and K8 L chains but creates an H chain 
that  requires  a  ~24  L  chain  for  PC  binding.  The T15- 
Ala-H:K24L gene combination (Table 1, cell line 5) results 
in  an  M167-Id +  antibody  that  binds  PC-BSA  with  an 
affinity 20-40 times lower than either the T15 (HPCM2) 
or M167 (HPCM27) standards. Additional amino acid changes 
at  the DJ junction appear  to  be  necessary to  produce a 
V.1:K24 antibody with affinity for PC equivalent to T15. 
Thus, the M167 H chain, which has six amino acid changes 
in its CDR3 compared with T15, generates an antibody with 
much higher affinity than the T15-Ala H chain when com- 
bined with a K24 L chain (Table 1, cell line 11). 
Characterization of N  Region-derived T15 Variant H  Chain 
Antibodies.  Further evidence of the importance of family- 
associated VD-junctional H chain amino acids in determining 
L chain composition in PC-binding antibodies was obtained 
when the variant T15-Asn-H gene was electroporated  into 
cells along with the three PC-binding L chain genes (Table 
1, cell lines 7-9). This H chain variant formed a PC-binding 
antibody with  an  affinity for PC-BSA  equivalent  to  the 
HPCM2-T15 standard when combined with the K8 L chain 
(cell line 9). No detectable binding to PC-BSA was observed 
in either the T15-Asn-H:K22L or T15-Asn-H:K24L antibodies 
(cell lines 7 and 8, respectively). It is interesting that all the 
T15-Ids analyzed, including the AB1.2 idiotope,  remained 
intact in  the non-PC-binding T15-Asn-H:K22L antibody, 
whereas, the M167 binding-site-specific idiotope,  28-5-15, 
was lost in the T15-Asn-H:K24L antibody. 
The final three cell lines (Table 1, cell lines 10-12), which 
were produced by combining the H chain gene from the M167 
myeloma (Fig. 1) with the three PC-binding L chain genes, 
confirmed the observations made with the T15-Ala H chain 
(cell lines 4-6). Thus, alteration of the T15 VD junction by 
insertion  of an Ala after Asp 95H produced an H  chain in 
which: (a) PC binding was achieved in association with a 
K24 L chain (cell line 11); (b) no binding to PC-BSA was 
seen when the M167 H chain was coexpressed in antibodies 
with either K22 or K8 L chains; and (c) the AB1.2 idiotope 
was lost in the antibody formed with the K22 L chain (cell 
line 10). 
Discussion 
The above data show that: (a) the germline T15H chain 
forms the highest affinity anti-PC antibody when associated 
with the K22 L chain, but it can form a low affinity anti-PC 
antibody when combined with the K8 L chain; (b) N region 
generation of a T15-Asn 95H chain variant is required to obtain 
a high affinity PC-binding antibody with the K8 L chain; 
(c) the germline T15-Ala H chain forms a PC-binding anti- 
body of low affinity when combined with a K24 L chain and 
additional N region or somatic mutations are required to ob- 
tain a high affinity anti-PC antibody with this H:L combi- 
nation; and (d) the VD-junctional amino acids Asp 95H, Asn 
95H, and Ala 96H are critical in determining which L chain 
generates a PC-binding antibody when associated with these 
variant H chains. Thus, K22 requires the Asp 95H, K24 re- 
quires the insertion of Ala or another residue at the VDjunc- 
tion, and K8 functions optimally with the Asn 95H variant 
in formation of PC-binding antibodies. All of these observa- 
tions lead to a molecular model to explain T15-idiotype dom- 
inance in the immune response to PC.  T15-Id dominance 
occurs because: (a) during embryonic and early neonatal devel- 
opment, when the H chain repertoire is restricted to germline- 
derived junctional sequences (23), T15H appears to be the 
most frequently rearranged  form of the V.l:DFL16.1:J,1 
gene segments (5); and, (b) this T15 H chain forms the highest 
affinity germline anti-PC antibody in association with the 
K22 L chain. Thus, even without the preferential recombina- 
tion of T15-1ike VD junctions in neonatal pre-B cells, PC- 
driven expansion of these T15-Id + B cells into a long-lived 
B cell pool would make this the dominant PC-specific clone. 
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receptors composed of T15H:K8L or T15-AIa-H:K24L mole- 
cules would not effectively compete with T15 clones for lim- 
iting PC antigen. The higher affinity M167- and M603-like 
anti-PC antibodies require N region diversification  to generate 
their H chain sequences and would, therefore, be generated 
at a very low frequency  in the newborn and adult bone marrow. 
The higher affinity phenylphosphocholine-specific B cells de- 
scribed by Stenzel-Poore et al. (35) do not compete with T15 
because they are not selectively amplified by the endogenous 
form of PC recognized by V,1 anti-PC antibodies. The on- 
going development of H chain transgenic mice carrying so- 
matic and germline H chain genes will allow us to test this 
model in bone marrow reconstitution studies where equal 
numbers of these clones can be allowed to compete for domi- 
nance of the peripheral anti-PC repertoire. However, the bi- 
ological  significance of the M167-1ike Ala-VD junctional 
change has been demonstrated in both M167 H chain (7) and 
~24 L chain (20) transgenic mice. In the M167 H chain trans- 
genic mice, all PC-specific  B cells  express the transgene-encoded 
H chain with an endogenous gene-encoded ~24 L chain, and 
in the L chain-transgenic mice, virtually all the PC antigen- 
induced antibodies express M167-1ike H chains with an extra 
VD-junctional amino acid, usually Ala, plus accompanying 
N region changes. Thus, in these M167 H or L transgenic 
mice, anti-PC antibodies with the appropriate  endogenous 
L chain or variant H chain are being selected by PC antigen. 
We are currently producing T15-Ala H chain-transgenic mice 
to determine the lower affinity limits for antigen-driven selec- 
tive expansion of PC-specific B cells in normal mice, and for 
clonal deletion of PC-specific B cells in xid mice. 
The lack of PC binding by the T15H:~24L antibody concurs 
with the H:L chain reconstitution studies of Sher et al. (36). 
When the $107 (T15) H chain was combined with theV~24 
L chain from the M511 myeloma, they found that the recom- 
binant antibody bound PC <10 and 30% as well as the pa- 
rental $107 and M511 antibodies, respectively. This residual 
binding could have been due to $107 L chain contamination. 
Furthermore, T15H:K24L-bearing B cells are not selected by 
antigen in the peripheral lymphoid tissues of IgAfc transgenic 
mice (37) expressing these genes (Kenny J. J., C. O'Connell, 
G. Guelde, J. Hurst, D. Lo, and D. L. Longo, manuscript 
in preparation).  These mice make predominantly T15-Id + 
anti-PC antibodies  in which the IgA transgene  product is 
coexpressed with endogenous K22 L chains. Since we have 
previously shown that peripheral selection of B cells appears 
to be an antigen-driven process (7), these data in IgAg trans- 
genic mice argue strongly that the T15H:K24L antibody is 
also not PC binding in vivo. 
If N region diversification is absent in the fetal and neo- 
natal mouse as suggested by Feeney (23), then our data sug- 
gest  that there are only three germline H:L combinations 
that produce anti-PC antibodies, T15H:K22L, T15H:K8L, and 
T15-Ala-H:g24L. Of these, T15H:~c22L has by far the highest 
affinity for PC and should be selectively expanded by autolo- 
gous or environmental antigen. When the T15H:g22L clone 
was suppressed during neonatal development by injection of 
anti-T15-Id  antibodies,  the  low  affinity  germline  clone 
T15H:KSL (HPCM3) (17), which binds PC with a Ka 10 
times lower than the T15 prototype antibody, was activated 
after immunization with PC. The decreased affinity of the 
T15H:K8L antibody compared with the T15H:K22L antibody 
could be due to the extra charge introduced by Asp 91L in 
the former. 
Padlan et al. (10) have suggested that the negatively charged 
carboxylate side chains of Asp 91L in M603 or Asp 95H in 
T15 and M167 are important for PC binding because of their 
interaction with the positively charged trimethylammonium 
moiety of PC. A higher affinity antibody is generated when 
the Asp 95H in the T15H gene is mutated to Ash as shown 
in the M603-like T15-AsnH:K8L antibody (Table 1, cell line 
9). This latter mutation restores the charge balance in the 
choline binding pocket.  It is interesting that no additional 
N region or somatic changes were necessary to achieve good 
binding to PC-BSA even though most M603-like antibodies 
have additional  N  region changes (t8,  22). No detectable 
binding to PC-BSA was observed in either the T15-Asn- 
H:K22L or T15-Asn-H:K24L antibodies  (cell lines 7 and 8, 
respectively). This observation confirms the key role that Asp 
95H plays in forming asalt bridge with the choline moiety 
of PC (.9-) in both the high and low affinity binding of the 
T15H:g22L and T15:~SL cell lines discussed above. The loss 
of this ionic bridge in the T15-AsnH:K22L and x24L anti- 
bodies is offset in the T15-Asn-H:g8L antibody by the nega- 
tively charged Asp 91L in the K8 L chain which cannot only 
reestablish the salt bridge with the choline moiety of PC, 
but also forms a stabilizing hydrogen bond with the Ash at 
95H (9,  10). 
The data in this paper support  the hypothesis that the B 
cells bearing the T15-Id dominate the immune response to 
PC because this H:L combination has the highest affinity 
for PC of the potential germline anti-PC antibodies, and these 
T15-Id* B cells are thus selectively amplified into the long- 
lived peripheral B cell pool by autologous or environmental 
antigen during early neonatal life. These long-lived neonataUy- 
derived T15H:g22L  B cells dominate the immune response 
to PC throughout adult life. As shown by Feeney (5), the 
adult bone marrow does not appear to regenerate the germ- 
line T15H  sequence because of extensive N  region diver- 
sification, and our data show that N region-modified T15H 
chains produce T15-Id + antibodies  that do not bind PC. 
Thus, the production of T15-Id + B cells capable of binding 
PC appears to be largely restricted to the perinatal period. 
The above observations and our previous publications  (6, 
7) demonstrating antigen-driven positive and negative selec- 
tion of PC-specific B cells in M167 H chain-transgenic mice 
strongly suggest that antigen, rather than an anti-Id network, 
drives the formation of the peripheral  B cell repertoire. 
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